Katerina Bakirtzi

Katerina Bakirtzi
Aristotle University of Thessaloniki | AUTH · Department of Dermatology and Venereal Diseases I

About

18
Publications
1,030
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
177
Citations

Publications

Publications (18)
Article
Full-text available
Atopic dermatitis (AD) is a chronic inflammatory dermatosis with periods of exacerbation and remissions. AD is characterized by intense, persistent pruritus and heterogeneity in clinical symptomatology and severity. Therapeutic goals include the amelioration of cutaneous eruptions, diminishing relapses and eventually the disease burden. To date, to...
Article
Full-text available
Scalp-localized psoriasis is common among patients affected with plaque psoriasis, rendering its treatment exceedingly difficult. Furthermore, the symptoms caused by the disease like scaling, erythema, and pruritus, among others, pose a major psychological impact and a significant regression in the quality of life of the affected patients. Biologic...
Article
Patients with psoriasis in difficult‐to‐treat areas experience substantial impairment in their welfare.1 Despite the remarkable efficacy of biologics, some patients may still suffer from residual disease in those sites affecting their everyday life.2,3 Therefore, we aimed to analyze the percentage of “very much” and “a lot” responses, identified as...
Article
High Covid‐19 vaccination rates are a prerequisite for the establishment of herd immunity 1. Psoriasis patients seem to be more inclined to undergo Covid‐19 vaccination, comparing to matched controls suffering from other skin diseases and receiving immunosuppressive treatment (odds ratio 1.32, 95% confidence interval 1.28–1.36).
Article
The clinical trials of the two novel COVID‐19 vaccines (Pfizer/BioNTech; Moderna) reported delayed local injection site reactions.1,2 Since vaccination rates increase, awareness of the adverse reactions is needed. This research letter reports a series of delayed localized hypersensitivity reactions to mRNA SARS‐CoV‐2 vaccines with histopathologic c...
Article
Full-text available
Actinic cheilitis is a premalignant condition that may evolve to squamous cell carcinoma. A consensus on its management has not been established, and large clinical trials are lacking. We aimed to review the existing data regarding the treatment of actinic cheilitis with various modalities regarding safety, efficacy, recursions, and post-treatment...
Article
Challenges in differential diagnosis of psoriasis from its mimickers is a possible scenario in clinical routine. Accurate dermoscopic criteria of various skin diseases exist, but the extent to which they improve diagnosis over the unaided‐eye examination in the real clinical setting remains unclear. To this extent, we sought to determine the contri...
Article
Apremilast was approved as an effective and safe treatment for psoriasis, but clinical trial results may differ from real‐life data. This retrospective cross‐sectional study evaluated the long‐term efficacy and safety of apremilast in a Greek cohort of adult psoriasis patients, who had received at least one dose of the drug between March 2016 and J...
Article
The COVID‐19 crisis represents a tipping point for teledermatology. Yet, many patients and physicians perceive teleconsultations as impersonal, while privacy concerns remain salient.1 Such issues may be addressed by a hybrid model of in‐person visits by primary care physicians (general practitioners or dermatologists) who may occasionally seek for...
Article
Psoriasis (Ps) is a chronic, immune‐mediated skin disease with systemic involvement. Therapeutic advancements in its management have considerably improved disease activity and quality of life, and reduced hospitalization rates. Nevertheless, prolonged immunosuppression in psoriatic patients may increase their susceptibility to opportunistic infecti...
Article
Superficial fungal infections are among the most frequent skin diseases worldwide.¹ Potential shifts in their epidemiological pattern are of great diagnostic and therapeutic importance. The large‐scale emigration in Europe has led many people to live in excessively congested places with limited access to proper hygiene and essential sanitation cond...
Article
Objective: The increasing number of elderly psoriatic patients presents a challenge for dermatologists. Biologicals and small-molecule inhibitors in the general population have demonstrated a sufficient efficacy and safety profile; yet, studies about their use in the geriatric population are lacking. In this study, we evaluated the efficacy and saf...
Article
COVID‐19 pandemic raised questions both in dermatologists and in patients about the use of immunosuppressive medications. Although dermatologic societies recommend the continuing of psoriatic systemic therapies and biologics, little is known about treatment adherence in psoriatic patients during COVID‐19 outbreak. Medication self‐management may fee...
Article
Full-text available
There are limited data regarding the association of actinic keratosis (AK) and other types of nonmelanoma skin cancer (NMSC); studies investigating possible correlation of AK with melanocytic naevi are even scarcer. To our knowledge, there are no data examining the risk of AK in people using specific medications. To investigate constitutional and e...

Network

Cited By